While EC17 dose-dependent apoptosis (Annexin V+) was seen in all FR+ tumor cell lines on day 2, high FR-expressing KB cells again showed disproportionally low apoptosis (Figure 4D). The gene discussed is ANXA5; the disease is neoplasm.